Source: Eyewire News

LumiThera: 01.03.2024 LumiThera Provides Update on FDA Review of Valeda Treatment for Dry AMD Patients

Read full article »

LumiThera's Competitors | LumiThera's News | LumiThera's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

President & CEO

Clark E. Tedford

CEO Approval Rating

90/100

LumiThera is a Washington-based medical device company that designs and develops photobiomodulation treatment protocols for the treatment of ocular disorders.